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ABSTRACT  Polyribocytidylate-3H-polyriboinosinate  (rC-3H:rI)  enters  cul-
tured  rabbit  kidney  cells  from  the  surrounding  medium  within  13  hr  after
exposure.  Grains  are found  in the  cytoplasm, nucleus,  and  nucleolus.  At  2 hr,
grains  are localized predominantly over the nucleolar regions.  Subsequently, the
grains  in the  nucleus  become  dispersed.  A specific  receptor site  for the  initia-
tion of interferon  production  was not revealed.
The  intracellular  fate  of  an  interferon  inducer,  double-stranded  polyribo-
cytidylate-3H-polyriboinosinate  (rC-3H:rI),  has been  studied by Bausek and
Merigan.l  Cellular  uptake  was first detected  after  3  hr  exposure,  when  the
grains were  localized  predominantly  over  the nucleolus.  Subsequently,  both
the cytoplasm and the nucleus were heavily labeled.
In  the  above  light  microscopic  study,  the  initially  observed  uptake  of
polyribonucleotide  was late in relation to interferon production,  and a specific
cellular receptor  site was not  revealed.  In  view  of the several  advantages  of
the  electron  microscope  over  the  light  microscope  in  radioautography,  the
study being reported  herein was undertaken  to determine  more precisely  the
intracellular localization  of rC-'H:rI in cultured rabbit kidney cells.
METHODS
Treatment of Cell Cultures with rC-'H:rI
Rabbit  kidney  cells  were  grown  in  35-mm  plastic  plates  as  previously  de-
scribed  (1).  rC-3H:rI  (specific  activity  6.97  mCi/mM  P,  labeled  only on  the
pyrimidine  moiety,  purchased  from  Schwarz  BioResearch,  Orangeburg,
N. Y.)  was  dissolved  in phosphate buffered  saline  (PBS),  pH  7.4,  and mixed
with a  solution  of cold rI.  (To make certain  that all rC-3H  was  in  a double-
1  G. H. Bausek  and T.  C.  Merigan.  1969.  Personal communication.
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stranded form, the molar  quantity of rI used  was double  that of rC-3H.)  The
double-stranded  rC-3H:rI,  but  not  its  single  stranded  constituents,  was
found  to  inhibit  plaque  formation  with  vesicular  stomatitis  virus  in  rabbit
kidney  cells  (1).
A set of cultures were  treated with either 0.8 or 3.2  LCi  of rC-3H:rI  in PBS
for  1 hr at 37 °C.  Thereafter,  the cells were washed to remove the unadsorbed
polynucleotide.  Further  incubation  was  carried  out  in  serum-free  minimal
essential  medium  (MEM).  Cultures  were  removed  for  electron  microscopy
at different  intervals,  ranging  from  30  min  to  6 hr  after  the addition  of rC-
3H:rI.
Preparation  for Electron Microscope Radioautography
The cultures were washed twice in cold PBS, fixed in cold 3% glutaraldehyde
in PBS for  1-12 hr,  postfixed  in  1  %  osmium tetroxide in PBS for  I hr,  passed
through  graded alcohols,  and embedded in Epon.
Thin  sections  were  mounted  on  Formvar-coated  grids  which  had  been
carbon-coated  prior  to  section  application.  The  sections  were  coated  with
emulsion bydipping in a 1: 2 dilution of Agfa-Gevaert NUC 307,  stored at 4 °C
in a  desiccator  for  3-12  wk,  developed  in Amidol  (18°C  for  6  min),  stained
with uranyl acetate,  and examined in a  Siemens  Elmiskop I.
RESULTS
Cellular  uptake  was  detected  as  soon  as  2  hr  after  exposure  to  rC-3H:rI.
The grains were distributed in the cytoplasm,  nucleus, and nucleolus  with no
evidence  of  preferential  localization  (Fig.  1).  At  2  hrs,  labeling  over  the
nucleolus  (Fig.  2)  exceeded  that found  over  other  regions  of  the  cell.  In
subsequent  periods,  the  grains  were  dispersed  and  no  longer  concentrated
over the nucleolus.
There was  some indication  that the polyribonucleotide  was  phagocytized;
grains were observed extracellularly  in the vicinity of projecting  cell processes
(Fig.  3),  within  intracytoplasmic  vacuoles  situated  close  to  the  cell  surface
(Fig.  4),  and  within  structures  resembling  autophagosomes.  No  specific
cellular receptor site was found,  since in addition to the structures enumerated
above,  labeling  was observed  among ribonucleoprotein  particles  (Fig.  5)  and
in  the  vicinity  of  vesicles,  mitochondria  (Fig.  2),  and  the  Golgi  apparatus
(Fig.  6).
DISCUSSION
Within  12  hr of exposure,  rC-3H:rI  enters  the rabbit kidney  cell and  attains
the nucleus and  nucleolus.  Thus,  this interferon  inducer  is distributed  within
the cell shortly prior  to the time when interferon  production  can  be detected,
namely,  between  1 and 3  hr after  exposure  (1).
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Since no serum  was added to the culture media used in our experiments, it
can  be  assumed  that the  extracellular  double-stranded  polynucleotide  was
not  degraded.'  However,  one  can  not  be  certain  that  intracellular  grains
represent  polynucleotide  in  the double-stranded  state; they may represent  a
degradation  product.  Furthermore,  at the  1 hr  point and  thereafter,  intra-
cytoplasmic  grains  may  represent  either  polynucleotide  which  has  entered
the cell from the surrounding  extracellular  medium or labeled rC which has
been  incorporated  into cellular  RNA  in  the  nucleus  and subsequently  re-
leased into the cytoplasm.  In agreement with Bausek and Merigan's  findings,
the predominantly nucleolar  localization  of the grains in the nucleus suggests
incorporation  into cellular RNA.
A specific  cellular  receptor  site for  the initiation  of interferon  production
was not revealed. Although there was suggestive  evidence for the phagocytosis
of rC:rI  by  rabbit kidney  cells,  a  definitive  statement  will  require  further
observations,  since  the  number  of  labeled  cells  represented  only  a  small
percentage  of those  sectioned.
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Discussions  from the Floor
Dr. Karl H. Fantes (Glaxo Research, Ltd.): I  would like to ask Dr. Field whether
there  was any correlation  between molecular  size of his poly  I:  poly C preparations
and toxicity.
Dr. Field: These studies are underway at the present. I don't really think we have
anything conclusive that I could  say at this point. This is  obviously a very important
point.
Dr. Marcel Pons (Public  Health  Research Institute):  I'd like to ask Dr. Field  if
he knows whether  the double-stranded  RNA that one can obtain from normal  chick
fibroblast  cells  will  stimulate  interferon  production?  And  secondly,  if you've  tried
polyanionic  compounds  like  polyvinyl  sulfate to see if that  will stimulate interferon
production.  I'm thinking  of Came's recent  work.
Dr. Field: In answer to your first question, when  Doctors Colby and Duesberg
went  into this, they did find some  RNase-resistant  RNA in normal  cells.  This RNA
did not  hybridize  with  the vaccinia  DNA,  so  this  was  probably  not virus-induced
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RNA.  It was tested  and  was found  to be inactive  as  an interferon inducer.  Dr. Mon- tagnier has also looked at this. I don't know anything about interferon induction here;
perhaps someone  else does.
Dr. De  Maeyer:  Since  Luc  Montagnier  is  a colleague  of  mine  at  the  Radium
Institute,  it  was  the  natural  thing for  us  to look  for  interferon  induction  with  the double-stranded  RNA  he  obtains from  normal rat liver cells,  and  which  most prob-
ably is not viral  RNA.  The  reason  for saying  it's not viral  RNA  is  that it does  hy- bridize with rat DNA to a high extent  (Montagnier and Harel, unpublished  results).
Now, when we put this double-stranded  rat liver RNA in tissue culture  of chick cells, mouse cells, and rat cells as well, we find very good interferon induction and inhibition
of viral  replication in these cultures.
Dr. Field:  You know,  maybe  this relates in some way to this constant  low level production of interferon  in cell cultures,  which  was mentioned previously.  There was a  second  question  that Dr.  Pons had,  and that  was  about  polyvinyl  sulfate.  No,  we
have not found polyvinyl  sulfates  active  as interferon  inducers in rabbits.
Dr. Baron: Concerning  the hypothesis  which Dr. Field  discussed,  that the infec- tion  by single-stranded  RNA virus  may induce  interferon only via  the  induction  of double-stranded,  replicative  form  of viral  RNA,  when  this hypothesis  was  first pro- posed,  it  remained  possible  that  the  greater  ribonuclease  stability  by  the  double-
stranded  RNA's  might  account  for their  larger  inducing  effect  as  compared  with
single-stranded  RNA. Therefore,  if single-stranded  RNA's  could  reach the cell with-
out being  destroyed,  they would  also induce interferon.
It has  been shown that single-stranded,  RNA's,  of synthetic,  natural,  viral  origin, or cellular origin,  can induce,  if one has a system where  RNAse activity is diminished
and where  the permeability  of the cell is increased  (Billiau et al.,  International  Sym-
posium  Interferon,  Lyon,  France,  1969.  In press).  Also  the work  by Dianzani  and Burke indicate  that input viral RNA,  presumably single-stranded,  could conceivably
induce  under  certain  conditions.  Since  most  naturally  occurring,  single-stranded
RNA's  have some  secondary  structure,  and since  many have  been  shown to  induce interferon,  by the criteria  offered,  we would  have to  relabel these RNA's  as  double-
stranded  or agree that previously defined  single-stranded  RNA can induce interferon.
The strandedness  of the  nucleic  acid inducers of interferon are of importance  for two reasons. It reflects  on the  natural mechanism by  which viruses induce interferon,  and
it helps in the search for new inducers.
Dr. Levy: The  secondary  structure  we have  referred to  is the  multistrandedness
arising when  one molecule  of hydrogen  bonds  to a  second  molecule,  not  the  base- stacking type  of secondary structure.  I  think that when you get into viral RNA's,  you have something more close to random copolymers  than anything else. You can't have the  sequences  alternating  in any regular  way,  because  the  sequences  have  to  carry
genetic information.
Dr. Field: Well,  I  think  this  argument  about  double-  and  single-strandedness
has  gone  round  and round  for  quite  awhile  without  much  progress.  Perhaps  Dr. Merigan has explained why single-stranded RNA  as an inducer may be active  to some extent.  Our insistence  has been on the activity of double-stranded  molecules.  Perhaps
this  ought  to  be  broken  down into  two  different  areas.  If one  looks  at the  practical problem  of induction,  there  is  induction  of  interferon  in  animals  and  induction  of
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resistance  against  virus  infections.  The  double-stranded,  complementary  RNA's
are excellent inducers.  The single-stranded  RNA's are, in our hands, noninducers,  and
I presume  also in Dr. Baron's  hands they  are  noninducers  of resistance  against virus
infection.
We come  down  to the academic  question  of whether single-stranded  RNA  mole-
cules  can  ever  induce  versus,  the  induction  that  is  obviously  present  with  double-
stranded  molecules.  I  think  we have  to look  at  several  points. The quantitative  dif-
ference is tremendous. You have about 1000-fold increased  activity in double-stranded
versus single-stranded  RNA. Now, if you want to look at the single-stranded molecule,
you have to account  for this difference and what might lie within the structure of that
molecule.  I  think  Dr.  Merigan's  explanations  of  areas  of  stability,  strandedness,
however  you want to  define this,  may  explain why these  single-stranded  RNA  mole-
cules may induce under certain circumstances.  As for induction during virus infection,
this  has previously  been discussed.  Another  question  is  the  possible  strandedness  or
complexity  of the input viral RNA.  I believe what  Dr. Lockart  saw with RNA  from
an  arbovirus  was  a  DNA-like  melting  profile  with  thermal  transition  midpoint  at
about 60°C. I do not suggest that this RNA was complementary  and double-stranded
in  terms  of two  separate,  covalently  bonded  polynucleotides,  but  I do  suggest  that
there  are  areas  of strandedness  and  that  this  may be  involved  in  the  induction  of
interferon.
From the floor: Dr. Field,  I would like to ask one thing. Most of your studies have
been done with  synthetic polynucleotide  inducers. What  is your comment  about  the
observation  that polynucleotide-induced  interferon  is resistant to actinomycin  D and
various  protein  synthesis  inhibitors,  while  viral  induced  interferon  is  sensitive  to
various  metabolic  inhibitors.  This  suggests  that,  as pointed  out  by  Dr. Youngner,
there  are several,  at  least  two,  types  of interferon  production in  cells-one  that  is
preformed  and another one that involves  de novo synthesis.
Dr. Field: I'm not in a position  to answer  that.  I should  ask Dr.  Vil6ek,  since
he just gave  a paper on this.
Dr. Jan Viliek (New York University School of Medicine):  I think this is a very
difficult question. The fact that there is a difference in the sensitivity of viral-induced
and  polyribonucleotide-induced  interferon  production  to  inhibitors  of  RNA  and
protein  synthesis  does  not  necessarily prove that there  is a difference  in the  actual
process of the production of this interferon. It may reflect a difference in the processing
of the inducer. I don't say that this is the case,  but we cannot exclude this possibility.
So I  think the problem  is wide  open, and my personal opinion is that there has been
enough circumstantial  evidence  accumulated in favor of the view that nucleic acid  is
the stimulus for interferon production in a virus infected cell,  although other factors
may be involved as well.
Dr. Levy:  In connection  with those last presentations,  I'm not quite sure about
the meaning of uptake  by cells of radioactivity  of poly I:  poly C. We have looked at
the uptake of radioactive double-labeled  poly I:  poly C made with 14C in the poly I
and tritium in the poly C.  We looked at uptake of this molecule in a variety  of dif-
ferent cells.  Basically, cells break down poly I:  poly C, and they break it down fairly
rapidly. Different  cells break it down to different extents;  some cells  break down the
poly I  more rapidly,  some  cells  break down the poly C  more rapidly. I'm no-  con-
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vinced  that this  is  going  to be  ultimately  meaningful  as far  as  biological  activity  is
concerned.
Dr.  De Maeyer  in his  presentation  showed  that  the  C-57  black  mice  produce  a
good deal  more interferon  than the  Balb/c  mice.  I  will present  some  work on  the
mechanism  of the  antitumor  action  of the  poly  I:poly C.  In connection  with that
study,  we have found that if you give mice poly I: poly C overnight and then studied
protein synthesis  or RNA synthesis from the various  organs of those mice,  you'll  find
that poly I:poly C exerts a strong effect.  In the  C-57 black mice, overnight treatment
with  poly  I:poly  C  leads  to  marked  augmentation  of proline  incorporation  into
many organs. With the Balb/c mice which are poor interferon inducers, poly I: poly C
treatment  overnight  leads  to marked  inhibitions  of protein  synthesis  in most  of the
organs. I'm not quite sure how this ties in, but there certainly appears to be some sort
of correlation.
And just to clarify this question of embryotoxicity, Dr. Adamson  is in the audience,
and I  hope he'll forgive me if I tell something about what he told me  the other day.
Dr.  Adamson  did  report  the embryotoxic  effects  of poly  I:poly  C  in rabbits.  Dr.
Hertz, on the other hand, found that mice show no such embryotoxic  effects, and Dr.
Adamson now finds that rats also show no such embryotoxic  effects.  I think the toxicity
of this  compound  in different  species  is  going  to  be  quite different.  Mice  are  quite
rugged against the action of poly I :poly C. Rabbits, I think, are quite sensitive; maybe
after a little while we'll know how humans react.
Dr. Porns: This  is just a suggestion.  I  perhaps  didn't make myself clear before.
Came has shown that polyvinyl sulfate is capable of stimulating interferon production.
As we showed recently,  polyvinyl  sulfate is capable of completely  replacing the RNA
on the ribonucleoprotein  of influenza,  thereby producing  a protein-polyvinyl  sulfate
complex.  I think it would  be very interesting to study the effects of a single-stranded
molecule,  polyvinyl  sulfate,  which  we  know  can  stimulate  interferon  to  a certain
extent,  and couple it with the protein portion of the ribonucleoprotein,  giving you, in
a  sense,  a double-stranded  molecule which has  all  the sedimentation  properties  and
morphological properties of the RNP,  and see what that does.
Dr. Carl A.  Pinto (Smith,  Kline  & French  Laboratories,  Philadelphia,  Pa.):  I
would like to address  another question to Dr. Field. Have you done any studies with
poly I: poly C in subhuman primates,  and if so, what is its capacity to induce interferon
in these species?
Dr. Field: We  have  looked  at  the  induction  of  interferon  in  African  Green
monkeys  and also the Rhesus  monkeys.  With the test systems  we have  available,  we
have not seen induction.
Dr. Gerald Mayer  (William  S.  Merrell  Co.,  Cincinnati,  Ohio):  I'd  like  to  ask
Dr.  De  Maeyer  if an  initial  myxovirus  stimulation  will  cause  a  refractory  state  to
subsequent  EMC  or poly I: C stimulation  of interferon.  In other words,  do you  see
tolerance to a subsequent injection of EMC or poly I: C if myxovirus is injected  first?
Dr. De Maeyer: That's an interesting problem, to see if viruses inducing interferon
production  of different  radiosensitivities  can  cause  refractory  states  to each  other's
interferon induction. We haven't examined this yet, but it's on our program.
Dr. Vilcek:  Dr. De Maeyer,  you  showed that the  difference  in the capacity  to
produce  high or  low quantities  of interferon  in different lines  of inbred  mice  is con-
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trolled by a single gene. Did you compare the ability of tissues isolated from these mice
in vitro to produce  interferon,  and was there  a quantitative  difference  also in vitro?
Dr. De Maeyer: Yes, we tried cells of different origins in an in vitro system.  First
of all,  peritoneal  macrophage  cultures,  derived from  Balb/c and from  C57BL mice,
when  stimulated  with  Newcastle  Disease  virus,  produced  about  equal  amounts  of
interferon;  in  other  words,  the  in vivo  difference  in interferon  production  was  not
reflected  in the macrophage  culture.  The second system  we tried  was  mouse embryo
fibroblasts.  NDV-induced  interferon production  was studied  in cultures derived from
either  Balb/c or  C57BL  mice.  Using this  approach,  we obtained conflicting  results;
sometimes  C57BL  fibroblasts  did  produce  more  interferon  than  Balb/c  fibroblasts,
and sometimes  the  interferon  productions  were  about  the  same.  Because  the  results
were  so irregular,  we abandoned  the system. The  third in vitro system  we tried were
heparinized  whole blood  suspensions obtained from  either C57BL  or Balb/c mice,  to
which NDV was added and left for about  18 hr at 37°C.  Using this approach,  whole
blood  suspensions  derived  from  C57BL  mice  produced  on  the  average  about  three
times  as  much  interferon  as  did whole  blood  suspensions  derived  from  Balb/c mice.
This  phenomenon  is quite reproducible  and furthermore,  in backcross  animals there
is a correlation between high interferon production in vivo and in vitro. Unfortunately,
as I indicated,  the difference  is only about threefold,  and therefore  the test is just not
good  enough  to  determine  mouse  genotype  in  vitro  (De  Maeyer,  E.,  and  J.
De Maeyer-Guignard.  1970. Ann. N. Y.  Acad. Sci. In press).
Dr. Viliek: But in any case this rules out the possibility that the difference among
these mice would  be not in interferon production  but in,  say, the rate of clearance  of
serum interferon.
Dr. De Maeyer: Also,  we did study clearance  of interferon  in Balb/c and  C57BL
mice by inoculating interferon and measuring rates of disappearance,  and we found no
difference between  the mouse strains.
Dr. Levy:  This is  in a nature  of a semiphilosophic  question  to  Dr.  De  Maeyer.
We've been speaking about the amount of interferon produced. You're really measur-
ing the biological activity of interferon  produced. Have you considered  the possibility
that really the nucleotide  sequence in the genes of the low producers is just coding for
an  interferon  molecule  that  is  somewhat  less  effective  than  that coded  for  by  the
nucleotide  sequence in the gene  of the high producer. You might be making the same
number of interferon molecules,  but that one just does not work as well as the other.
Dr. De Maeyer: I know, we have also thought of this; maybe the same number of
interferon molecules  is made by Balb/c mice, but they are less efficient in inducing the
antiviral  state.  I  cannot  answer  your question,  and- I  do  not know  how  one  could,
since the only way of measuring interferon is by its antiviral activity.  We did compare
molecular weights  of NDV-induced serum interferon  of Balb/c and C57BL mice,  and
we found  in both cases a heavy  and light peak.  The heavy  peak was proportionally
less  important  in C57BL  mice,  and this may be some  evidence  for a qualitative  dif-
ference. Another experiment we did, but that doesn't really answer the question either,
was  to  measure  C57BL  and  Balb/c  serum  interferon  activity  in  both  C57BL-  and
Balb/c-derived  fibroblast cultures. Both interferons had comparable  activity in Balb/c
and C57BL cells.
Dr. Field: In Dr.  Vil6ek's paper he mentioned that there was repression  of early
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interferon production in poly I: poly C-induced rabbit kidney cells, by cycloheximide.
I would like to comment on some work we have done along these lines. In our experi-
ments, primary  rabbit  kidney  cells  as  monolayers  were  treated  with  1  tg poly  I:
poly C/ml instead of with the 40  ug/ml which he used,  incubated for  2 hr, and then
washed  free  of residual  inducer.  These  cells  were  trypsinized  off the glass,  put  into
suspension  in spinner flasks, and either incubated in the presence of cycloheximide at
10 ug/ml or without the cycloheximide.  What we saw there was a marked suppression
of the  production  of interferon.  We're  looking  at  hourly  production  of interferon
within the first 3-4 hr, and we saw a marked suppression of production of interferon.
What happened  after that I was surprised at, and apparently Dr. Vilcek's data explain
what was happening.  We saw tremendous increases  in interferon  production.
Dr. Friedman: Just a  comment.  In  speaking  about the induction  of interferon
by virus infection, I think people are a little too fast in talking about  a replicative form
and  a  partly  double-stranded  RNA  replicative  intermediate.  I  think  the  data  of
Weismann have brought up really serious objections  to the idea that these things exist
as such in the cell.  He has  shown that during the extraction of RNA,  one probably
hybridizes  negative and positive strands.  For the most part, the negative strand seems
to exist  as a single-stranded  molecule  within  the cell  in its natural  state. There  is  a
very strong  evidence  in favor  of that.  One should keep  this  in mind when  speaking
about natural induction  of interferon  by viral double-stranded  RNA. It may really
not exist in this form.
Dr. George Miroff  (Union  College):  Dr.  De Maeyer,  you  made  a  considerable
point about  differences  between  the Balb/c  and the  C57 strains  of mice.  I presume
then you referred to the tumor incidence in the two strains and tried to correlate that
with the interferon production in these two species.  Is that correct?
Dr. De Maeyer: We have  not correlated  it yet;  this  is  what we  are  attempting
now,  using F2 and  backcross generations.
Dr. Miroff: Well,  I  presume  then  that  you  meant  the  ability  to  produce  the
virus was different in these two particular species,  is that correct?
Dr. De Maeyer: No,  what I'm saying  is that  it  is well  known  that most  C57BL
strains  are quite resistant  to the induction  of leukemia by Friend  or Rauscher virus,
to polyoma  virus,  and to the mammary  tumor virus.  As you  know,  Balb/c mice  in
general  are  quite susceptible  to  those  agents.  And  what  we  are  doing  now,  using
backcross  and F2 generation animals,  is to  find out if segregation of resistant animals
and high interferon producers  is  to some extent correlated  or not.
Dr. Miroff: Well,  no doubt  you are  aware  of the  fact  that  C-57  mice will  not
develop a tumor when the mammary tumor agent is introduced  and  will continue to
produce  a  transmissible  factor as evidenced  by the production  of tumors  in agent-
free,  susceptible  young  which  she  has  foster  nursed.  This  was  done  years  ago  by
Andervondt. In addition, Haagensen  and Moore used C-57  as a bioassay  animal for
tumor production.
Now,  I  think  the  two  questions,  tumor  production  and  the  production  of  the
transmissible  factor,  should  be  clearly  distinguished.  As  far  as  the  production  of
virus or  transmissible  material  is concerned,  C-57 and  the Balb/c  are really  not too
different.
Dr. De Maeyer: As far as what  is concerned?
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Dr. Miroff: The ability to transmit or produce the virus or  transmissible  factor
for production  of mammary tumors.
Dr. De Maeyer: I believe  it depends on what C-57 strain you are talking  about.
You are talking about the C-57 strain which is susceptible to mammary tumor agent,
which is Dr. Moore's strain I believe.
Dr. Miroff: But we  have  C-57 mice that  do not  develop  tumors but that will
continue to produce mammary tumor agent.
Dr. De Maeyer: But  the C-57/BL  strains  we  are working  with  are resistant  to
induction of mammary tumors.
Dr. Miroff: Our C-57 mice are too, but do your C-57 mice continue to produce
the  transmissible factor?
Dr. De Maeyer: I don't know.